Search results
CMS Hosts Health Equity Conference: Key Insights and Perspectives | JD Supra
JD Supra· 20 hours agoLast week, the Centers for Medicare & Medicaid Services (CMS) held the second annual Health Equity Conference. The event drew several hundred in-person attendees, including ...
After A 40% Fall Is Walgreens Stock A Better Pick Over CVS Health?
Forbes· 2 days agoGiven its better valuation, we believe Walgreens stock (NYSE: WBA) is a better pick than its peer...
Do patients recommend your metro-east hospital? See Illinois report card results
Belleville News-Democrat· 2 days agoThe Illinois Department of Public Health launched an “enhanced” version of a tool meant to help evaluate local health care facilities in October, and patient recommendation rates for local hospitals ...
Ensign Group (ENSG) Buys Facilities in Arizona & Colorado
Zacks· 2 days agoThis acquisition was completed through a subsidiary of ENSG’s captive real estate entity, Standard Bearer Healthcare REIT, Inc., and took effect on Jun 1, 2024. The buyout ...
What's Motivating Docs to Lobby Lawmakers
Medscape· 7 days agoIf you interviewed a dozen medical students, chances are very few would 1 day think they'd spend time lobbying their local, state, or federal legislators...
Traumatic brain injury affects 1 in 8 older Americans
UPI· 6 days agoMedicare data shows that about 13% of seniors suffered a severe concussion during an average...
Project 2025 Has Bad Medicine for HHS
The Nation· 3 days agoDuring Severino’s time there, Trump’s Department of Health and Human Services weakened the Affordable Care Act; strengthened the ability of healthcare...
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
Zacks via Yahoo Finance· 3 days agoEarlier this month, the company received a permanent Healthcare Common Procedure Coding System...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen...
Morningstar· 1 day agoPomerantz LLP announces that a class action lawsuit has been filed against Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB) and certain officers. The class action, filed in the
Analysis | A flash point on birth control access
Washington Post· 2 days agoToday’s newsletter top draws from the deep reporting of my Post colleague Lauren Weber, who covers the forces promoting scientific and medical...
